1. Program Coordinator: Laura Kasman, Ph.D. [email_address] 2. M&I program currently 17 Ph.D. students 4 MD/Ph.D. students 1 DMD/Ph.D. student 2 Masters students 15 Departmental…
1. WELCOME TO EUFETS GMBHYour Provider ofIntegrated Product Development Services for Cell & Gene TherapyEUFETS GmbH - A Company of BioNTech AG 2. EUFETS is part of BioNTech…
4 Biological Products: Manufacturing, Handling, Packaging and Storage Nahla S. Barakat King Saud University, College of Pharmacy, Dept. of Pharmaceutics, Saudi Arabia 1.…
Slide 1 16 th Annual NIH SBIR/STTR Conference Functional Down-to-Earth Advice for understanding the FDA Chris Sasiela, PhD, RAC NHLBI Office of Translational Alliances and…
Slide 1 European Parliament Advanced Therapies Hearing May 11, 2006 Advanced Therapies The proposed EU regulation from the viewpoint of a Pharmaceutical company with experience…
Mitochondrial Manipulation Technology in Assisted Reproduction For the Prevention of Transmission of Mitochondrial Disease or Treatment of Infertility Deborah Hursh, Ph.D.…
Innovation Through Collaboration: Why the CSS Working Groups are Important to the FDA Steve Wilson, DrPH, CAPT USPHS Director, FDA/CDER/OTS/OB/DBIII 2014 Computational Science…
The FDA Review Process Dan Takefman, PhD Chief, Gene Therapy Branch DCGT/OCTGT/CBER/FDA IOM Meeting 6/4/13 Overview IND Review Process Regulatory framework Discipline review…